Clinical Trials
19
Active:3
Completed:4
Trial Phases
4 Phases
Phase 2:2
Phase 3:1
Phase 4:5
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Not Applicable
9 (52.9%)Phase 4
5 (29.4%)Phase 2
2 (11.8%)Phase 3
1 (5.9%)EMERALD TRIAL Open Label Extension Study
Phase 4
Active, not recruiting
- Conditions
- Motor Neuron DiseaseAmyotrophic Lateral SclerosisCannabisCBD
- Interventions
- First Posted Date
- 2021-08-10
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- Gold Coast Hospital and Health Service
- Target Recruit Count
- 7
- Registration Number
- NCT04997954
- Locations
- 🇦🇺
Gold Coast Hospital and Health Service, Gold Coast, Queensland, Australia
Low Carbohydrate Diet, Glycaemic Control and Quality of Life in Australian Adults With Type 1 Diabetes
Completed
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2019-12-30
- Last Posted Date
- 2021-12-02
- Lead Sponsor
- Gold Coast Hospital and Health Service
- Target Recruit Count
- 23
- Registration Number
- NCT04213300
- Locations
- 🇦🇺
Gold Coast Hospital and Health Service, Gold Coast, Queensland, Australia
A Comparison of Brief Cognitive Behavioural Therapy (CBT) and the Attempted Suicide Short Intervention Program
Not Applicable
- Conditions
- Suicide, Attempted
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Gold Coast Hospital and Health Service
- Target Recruit Count
- 411
- Registration Number
- NCT04072666
- Locations
- 🇦🇺
Gold Coast Hospital Health, Gold Coast, Queensland, Australia
Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms
- Conditions
- Intracranial AneurysmStroke, AcuteCerebral AneurysmCerebral HemorrhageSubarachnoid HemorrhageCerebral StrokeNeurologic Disorder
- First Posted Date
- 2019-01-24
- Last Posted Date
- 2019-12-10
- Lead Sponsor
- Gold Coast Hospital and Health Service
- Target Recruit Count
- 500
- Registration Number
- NCT03815149
- Locations
- 🇦🇺
Prince of Wales Hospital, Sydney, New South Wales, Australia
🇦🇺Liverpool Hospital, Sydney, New South Wales, Australia
🇦🇺Gold Coast University Hospital, Gold Coast, Queensland, Australia
Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease
Phase 3
Active, not recruiting
- Conditions
- Amyotrophic Lateral SclerosisMotor Neuron Disease
- Interventions
- Drug: Placebo Oil
- First Posted Date
- 2018-10-01
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- Gold Coast Hospital and Health Service
- Target Recruit Count
- 17
- Registration Number
- NCT03690791
- Locations
- 🇦🇺
Gold Coast Hospital and Health Service, Gold Coast, Queensland, Australia
- Prev
- 1
- 2
- Next
News
No news found